SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PROTEOMICS -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (396)2/8/2002 3:24:26 PM
From: nigel bates  Read Replies (1) | Respond to of 539
 
More details from Genomeweb -

 In order to create a proteome profile characteristic of the disease, the researchers used SELDI-TOF machines from Ciphergen Biosystems to analyze protein content in 100 blood samples, generating more than 15,000 data points per patient. They then used Correlogic's Proteome Quest bioinformatics tool to isolate protein abundance patterns that would be able to conclusively identify cancer patients...



To: nigel bates who wrote (396)2/9/2002 1:28:35 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 539
 
Wow.

Makes me want to go rent some lab space and start to make antibodies again. I didn't think that we'd see this sort of advance for years.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News